Cogent Biosciences, Inc. Proceeds from Issuance of Private Placement
Cogent Biosciences, Inc. (COGT) reported Proceeds from Issuance of Private Placement of $213.30 million for the 1-month period ending 2024-02-29, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-11-07
- Cogent Biosciences, Inc. proceeds from issuance of private placement for the quarter ending 2018-12-31 was $0.00.
- Cogent Biosciences, Inc. proceeds from issuance of private placement for the quarter ending 2018-09-30 was $0.00.
- Cogent Biosciences, Inc. proceeds from issuance of private placement for fiscal 2018 was $5.00M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 1 month as first filed | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|
| 2024-02-29 | $213.30M 10-Q · filed 2025-11-07 | $213.40M 10-Q · filed 2024-05-07 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $5.00M 10-K · filed 2020-03-26 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $5.00M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $5.00M 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |